FOXO3 and cancer: We found no evidence to support that methylation at any of the 45 sites in FOXO3 was associated with risk of cancer overall or specific type (p > 1.23 × 10−4), and this finding remained the same after adjustment for lifestyle-related variables (smoking, alcohol consumption, and BMI), as in Table S4.